BMRN vs KXIN · P/E 40, rev $1.76B vs rev $129.0K
Biomarin Pharmaceutical Inc (BMRN) versus Kaixin Auto Holdings (KXIN) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Kaixin Auto Holdings (KXIN) is a auto & truck dealerships company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported KXIN revenue for 2025-12-31 was $129.0K. Net income was -$53.9M. Revenue was down 99.6% from 2023-12-31 to 2025-12-31. KXIN currently screens at market cap $8.0M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. KXIN currently screens at market cap $8.0M.
Not investment advice. Open the BMRN and KXIN stock pages for the full models.
Not investment advice.